Apremilast
-
Post Date:
Nov 13,2014
-
Expiry Date:
May 12,2015
-
Detailed Description:
Cas No. :608141-41-9
Apremilast (brand name Otezla) is an orally available small molecule inhibitor of phosphodiesterase 4 (PDE4). Apremilast specifically inhibits PDE4 and inhibits spontaneous production of TNF-alpha from human rheumatoid synovial cells. It has anti-inflammatory activity.
molecular formula:C22H24N2O7S
molecular weight:460.5
-
CAS Registry Number:
608141-41-9
-
Synonyms:
;N-{2-[(1S)-1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl]-1,3-dioxo-2,3-dihydro-1H-isoindol-4-yl}acetamide;Unii-up7qbp99pn;(S)-N-(2-(1-(3-Ethoxy-4-methoxyphenyl)-2-(methylsulfonyl)ethyl)-1,3-dioxoisoindolin-4-yl)acetamide;(S)-2-[1-(3-Ethoxy-4-methoxyphenyl)-2-methylsulfonylethyl]-4-acetylaminoisoindoline-1,3-dione;CC 10004;
-
Molecular Formula:
C22H24N2O7S
-
Molecular Weight:
460.500214
-
Molecular Structure:
Inquiry